Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy ; day:22 ; month:7 ; year:2024 ; pages:1-15
Basic research in cardiology ; (22.7.2024), 1-15
- Urheber
-
Buehning, Florian
Lerchner, Tobias
Vogel, Julia
Hendgen-Cotta, Ulrike B.
Totzeck, Matthias
Rassaf, Tienush
Michel, Lars
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00395-024-01070-0
- URN
-
urn:nbn:de:101:1-2410072104320.154681202193
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Buehning, Florian
- Lerchner, Tobias
- Vogel, Julia
- Hendgen-Cotta, Ulrike B.
- Totzeck, Matthias
- Rassaf, Tienush
- Michel, Lars
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cardiotoxicity risk factors with immune checkpoint inhibitors
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
A comprehensive review on immune checkpoint inhibitors induced cardiotoxicity characteristics and associated factors
A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
Immune checkpoint inhibitor-induced cardiotoxicity in patients with lung cancer: a systematic review and meta-analysis
Cardiotoxicity during checkpoint inhibitor therapy in patients with advanced skin cancer
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cardiotoxicity risk factors with immune checkpoint inhibitors
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
A comprehensive review on immune checkpoint inhibitors induced cardiotoxicity characteristics and associated factors
A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
Immune checkpoint inhibitor-induced cardiotoxicity in patients with lung cancer: a systematic review and meta-analysis
Cardiotoxicity during checkpoint inhibitor therapy in patients with advanced skin cancer
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cardiotoxicity risk factors with immune checkpoint inhibitors
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
A comprehensive review on immune checkpoint inhibitors induced cardiotoxicity characteristics and associated factors
A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
Immune checkpoint inhibitor-induced cardiotoxicity in patients with lung cancer: a systematic review and meta-analysis
Cardiotoxicity during checkpoint inhibitor therapy in patients with advanced skin cancer
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity